Mir-29c and Mir-424 Are Novel Myeloid Differentiation-Associated MicroRNAs in Acute Promyelocytic Leukemia

被引：0
|
作者：
Batliner, Jasmin [1 ]
Jenal, Mathias [1 ]
Fey, Martin F. [2 ]
Tschan, Mario P. [1 ]
机构：
[1] Univ Bern, Dept Clin Res, Bern, Switzerland
[2] Univ Bern, Inselspital, CH-3010 Bern, Switzerland
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1149 / 1149
页数：1
相关论文
共 50 条
  • [1] MiR-424 and miR-27a increase TRAIL sensitivity of acute myeloid leukemia by targeting PLAG1
    Sun, Yan-ping
    Lu, Fei
    Han, Xiao-yu
    Ji, Min
    Zhou, Ying
    Zhang, A-min
    Wang, Hong-chun
    Ma, Dao-xin
    Ji, Chun-yan
    ONCOTARGET, 2016, 7 (18) : 25276 - 25290
  • [2] Circulating miR-29b and miR-424 as Prognostic Markers in Patients with Acute Cerebral Infarction
    Zhang, Yue-Zhan
    Wang, Jun
    Xu, Feng
    CLINICAL LABORATORY, 2017, 63 (10) : 1667 - 1674
  • [3] Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation
    Forrest, A. R. R.
    Kanamori-Katayama, M.
    Tomaru, Y.
    Lassmann, T.
    Ninomiya, N.
    Takahashi, Y.
    de Hoon, M. J. L.
    Kubosaki, A.
    Kaiho, A.
    Suzuki, M.
    Yasuda, J.
    Kawai, J.
    Hayashizaki, Y.
    Hume, D. A.
    Suzuki, H.
    LEUKEMIA, 2010, 24 (02) : 460 - 466
  • [4] Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation
    Forrest, A. R. R.
    Kanamori-Katayama, M.
    Tomaru, Y.
    Lassmann, T.
    Ninomiya, N.
    Takahashi, Y.
    de Hoon, M. J. L.
    Kubosaki, A.
    Kaiho, A.
    Suzuki, M.
    Yasuda, J.
    Kawai, J.
    Hayashizaki, Y.
    Hume, D. A.
    Suzuki, H.
    DIFFERENTIATION, 2010, 80 : S31 - S31
  • [5] Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation
    A R R Forrest
    M Kanamori-Katayama
    Y Tomaru
    T Lassmann
    N Ninomiya
    Y Takahashi
    M J L de Hoon
    A Kubosaki
    A Kaiho
    M Suzuki
    J Yasuda
    J Kawai
    Y Hayashizaki
    D A Hume
    H Suzuki
    Leukemia, 2010, 24 : 460 - 466
  • [6] Clinical response to azacitidine therapy depends on microRNA-29c (miR-29c) expression in older acute myeloid leukemia (AML) patients
    Butrym, Aleksandra
    Rybka, Justyna
    Baczynska, Dagmara
    Poreba, Rafal
    Kuliczkowski, Kazimierz
    Mazur, Grzegorz
    ONCOTARGET, 2016, 7 (21) : 30250 - 30257
  • [7] Discovery and Functional Implications of a Novel Mir-29b/Mir-29a Polymorphism in Acute Myeloid Leukemia
    Garzon, Ramiro
    Heaphy, Catherine E. A.
    Stauffer, Nicole
    Havelange, Violaine
    Volinia, Stefano
    Andreeff, Michael
    Croce, Carlo M.
    BLOOD, 2009, 114 (22) : 781 - 782
  • [8] Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine
    Tang, Li-juan
    Sun, Guo-kang
    Zhang, Ting-juan
    Wu, De-hong
    Zhou, Jing-dong
    Ma, Bei-bei
    Xu, Zi-jun
    Wen, Xiang-mei
    Chen, Qin
    Yao, Dong-ming
    Qian, Jun
    Ma, Ji-chun
    Lin, Jiang
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [9] Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine
    Li-juan Tang
    Guo-kang Sun
    Ting-juan Zhang
    De-hong Wu
    Jing-dong Zhou
    Bei-bei Ma
    Zi-jun Xu
    Xiang-mei Wen
    Qin Chen
    Dong-ming Yao
    Jun Qian
    Ji-chun Ma
    Jiang Lin
    Cancer Cell International, 19
  • [10] Cytotoxic effect of Artesunate on myeloid leukemia cell lines through up-regulating miR-29c expression
    Dou, Cui-Yun
    Liu, Lu-Lu
    Li, Feng
    Liu, Lei
    Wang, Cui-Ling
    Wang, Li-Na
    Wang, Hai-Hua
    Zhang, Hao
    Chen, Ming-Tai
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (06) : 1748 - 1750
12345